Your browser doesn't support javascript.
loading
Highly susceptible SARS-CoV-2 model in CAG promoter-driven hACE2-transgenic mice.
Asaka, Masamitsu N; Utsumi, Daichi; Kamada, Haruhiko; Nagata, Satoshi; Nakachi, Yutaka; Yamaguchi, Tomokazu; Kawaoka, Yoshihiro; Kuba, Keiji; Yasutomi, Yasuhiro.
Affiliation
  • Asaka MN; Laboratory of Immunoregulation and Vaccine Research, Tsukuba Primate Research Center.
  • Utsumi D; Laboratory of Immunoregulation and Vaccine Research, Tsukuba Primate Research Center.
  • Kamada H; Laboratory of Biopharmaceutical Research, and.
  • Nagata S; Laboratory of Antibody Design, National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN), Ibaraki, Japan.
  • Nakachi Y; Global Center for Medical Engineering and Informatics, Osaka University, Suita, Japan.
  • Yamaguchi T; Laboratory of Antibody Design, National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN), Ibaraki, Japan.
  • Kawaoka Y; Department of Molecular Brain Science, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.
  • Kuba K; Department of Biochemistry and Metabolic Science, Graduate School of Medicine, Akita University, Akita, Japan.
  • Yasutomi Y; Influenza Research Institute, Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin, Madison, USA.
JCI Insight ; 6(19)2021 10 08.
Article in En | MEDLINE | ID: mdl-34463644

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Angiotensin-Converting Enzyme 2 / COVID-19 Limits: Animals Language: En Journal: JCI Insight Year: 2021 Document type: Article Country of publication: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Angiotensin-Converting Enzyme 2 / COVID-19 Limits: Animals Language: En Journal: JCI Insight Year: 2021 Document type: Article Country of publication: United States